Lazard Asset Management LLC C4 Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.18 - $6.03 $14,602 - $74,621
12,375 New
12,375 $69,000
Q3 2022

Nov 14, 2022
BUY
$8.03 - $12.77 $37,620 - $59,827
4,685 New
4,685 $41,000
Q2 2022

Aug 09, 2022
SELL
$5.06 - $26.46 $19,400 - $101,447
-3,834 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$19.99 - $33.23 $76,641 - $127,403
3,834 New
3,834 $93,000

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $208M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email